SLC12A5 and Huntington disease: Since KCC2 and NKCC1 expressions and functionality are crucial in determining the effects of GABA dysregulated KCC2 and NKCC1 activities [32,46,58,72], subsequent abnormalities in GABAergic signalling are thought to contribute to HD pathogenesis [2].